Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines [NA]

View source ↗

Summary

Safety and efficacy results from a completed clinical trial evaluating botulinum toxin type A for forehead and frown lines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Rhytides
• Glabellar Frown Lines

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Facial Rhytides, Glabellar Frown Lines | NA | Status: COMPLETED | Results posted: 2012-11-26